Have a feature idea you'd love to see implemented?
Let us know!
BSX Boston Scientific Corp
Price (delayed)
$91.5
Market cap
$134.86B
P/E Ratio
75
Dividend/share
N/A
EPS
$1.22
Enterprise value
$143.24B
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology,
Highlights
The EPS has increased by 49% YoY
Boston Scientific's net income has increased by 46% YoY
BSX's quick ratio is up by 27% year-on-year but it is down by 11% since the previous quarter
The P/E is 24% above the last 4 quarters average of 60.4 and 2.6% above the 5-year quarterly average of 73.1
Boston Scientific's debt has increased by 22% YoY and by 3% QoQ
Key stats
What are the main financial stats of BSX
Market
Valuations
Earnings
Shares outstanding
1.47B
Market cap
$134.86B
Enterprise value
$143.24B
Price to book (P/B)
6.51
Price to sales (P/S)
8.47
EV/EBIT
57.41
EV/EBITDA
38.41
EV/Sales
9
Revenue
$15.91B
EBIT
$2.5B
EBITDA
$3.73B
Free cash flow
$2.18B
Per share
Balance sheet
Liquidity
EPS
$1.22
Free cash flow per share
$1.48
Book value per share
$14.06
Revenue per share
$10.8
TBVPS
$11.74
Total assets
$38.08B
Total liabilities
$17.12B
Debt
$10.89B
Equity
$20.71B
Working capital
$2.85B
Debt to equity
0.53
Current ratio
1.48
Quick ratio
0.85
Net debt/EBITDA
2.25
Margins
Efficiency
Dividend
EBITDA margin
23.4%
Gross margin
69%
Net margin
11.3%
Operating margin
15.8%
Return on assets
4.9%
Return on equity
8.9%
Return on invested capital
13%
Return on capital employed
7.8%
Return on sales
15.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BSX stock price
How has the Boston Scientific stock price performed over time
Intraday
1.47%
1 week
4.46%
1 month
3.92%
1 year
65.4%
YTD
58.28%
QTD
9.19%
Financial performance
How have Boston Scientific's revenue and profit performed over time
Revenue
$15.91B
Gross profit
$10.97B
Operating income
$2.51B
Net income
$1.79B
Gross margin
69%
Net margin
11.3%
Boston Scientific's net income has increased by 46% YoY
Boston Scientific's net margin has increased by 27% YoY but it has decreased by 6% QoQ
Boston Scientific's operating income has increased by 16% YoY
The revenue has increased by 16% YoY and by 4.5% from the previous quarter
Growth
What is Boston Scientific's growth rate over time
Valuation
What is Boston Scientific stock price valuation
P/E
75
P/B
6.51
P/S
8.47
EV/EBIT
57.41
EV/EBITDA
38.41
EV/Sales
9
The EPS has increased by 49% YoY
The P/E is 24% above the last 4 quarters average of 60.4 and 2.6% above the 5-year quarterly average of 73.1
The stock's price to book (P/B) is 63% more than its 5-year quarterly average of 4.0 and 25% more than its last 4 quarters average of 5.2
The equity has grown by 10% YoY
BSX's P/S is 54% above its 5-year quarterly average of 5.5 and 21% above its last 4 quarters average of 7.0
The revenue has increased by 16% YoY and by 4.5% from the previous quarter
Efficiency
How efficient is Boston Scientific business performance
The return on assets has grown by 36% year-on-year but it has declined by 3.9% since the previous quarter
The return on equity has increased by 35% year-on-year but it has declined by 4.3% since the previous quarter
BSX's ROIC is up by 9% YoY
Dividends
What is BSX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BSX.
Financial health
How did Boston Scientific financials performed over time
Boston Scientific's total assets is 122% more than its total liabilities
BSX's quick ratio is up by 27% year-on-year but it is down by 11% since the previous quarter
BSX's total liabilities is up by 15% year-on-year and by 3.8% since the previous quarter
Boston Scientific's debt is 47% lower than its equity
Boston Scientific's debt has increased by 22% YoY and by 3% QoQ
Boston Scientific's debt to equity has increased by 13% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.